Probabilistic Proton Treatment Planning: a novel approach for optimizing underdosage and overdosage probabilities of target and organ structures

2025-07-03T08:21:47Z

Treatment planning uncertainties are typically managed using margin-based or robust optimization. Margin-based methods expand the clinical target volume (CTV) to a planning target volume, generally unsuited for proton therapy. Robust optimization considers worst-case scenarios, but its quality depends on the uncertainty scenario set: excluding extremes reduces robustness, while too many make plans overly conservative. Probabilistic optimization overcomes these limits by modeling a continuous scenario distribution. We propose a novel probabilistic optimization approach that steers plans toward individualized probability levels to control CTV and organs-at-risk (OARs) under- and overdosage. Voxel-wise dose percentiles ($d$) are estimated by expected value ($E$) and standard deviation (SD) as $E[d] \pm δ\cdot SD[d]$, where $δ$ is iteratively tuned to match the target percentile given Gaussian-distributed setup (3 mm) and range (3%) uncertainties. The method involves an inner optimization of $E[d] \pm δ\cdot SD[d]$ for fixed $δ$, and an outer loop updating $δ$. Polynomial Chaos Expansion (PCE) provides accurate and efficient dose estimates during optimization. We validated the method on a spherical CTV abutted by an OAR in different directions and a horseshoe-shaped CTV surrounding a cylindrical spine. For spherical cases with similar CTV coverage, $P(D_{2\%} > 30 Gy)$ dropped by 10-15%; for matched OAR dose, $P(D_{98\%} > 57 Gy)$ increased by 67.5-71%. In spinal plans, $P(D_{98\%} > 57 Gy)$ increased by 10-15% while $P(D_{2\%} > 30 Gy)$ dropped 24-28%. Probabilistic and robust optimization times were comparable for spherical (hours) but longer for spinal cases (7.5 - 11.5 h vs. 9 - 20 min). Compared to discrete scenario-based optimization, the probabilistic method offered better OAR sparing or target coverage depending on the set priorities.

A dynamic reconstruction and motion estimation framework for cardiorespiratory motion-resolved real-time volumetric MR imaging (DREME-MR)

2025-07-02T23:15:07Z

Based on a 3D pre-treatment magnetic resonance (MR) scan, we developed DREME-MR to jointly reconstruct the reference patient anatomy and a data-driven, patient-specific cardiorespiratory motion model. Via a motion encoder simultaneously learned during the reconstruction, DREME-MR further enables real-time volumetric MR imaging and cardiorespiratory motion tracking with minimal intra treatment k-space data. From a 3D radial-spoke-based pre-treatment MR scan, DREME-MR uses spatiotemporal implicit-neural-representation (INR) to reconstruct pre-treatment dynamic volumetric MR images (learning task 1). The INR-based reconstruction takes a joint image reconstruction and deformable registration approach, yielding a reference anatomy and a corresponding cardiorespiratory motion model. The motion model adopts a low-rank, multi-resolution representation to decompose motion fields as products of motion coefficients and motion basis components (MBCs). Via a progressive, frequency-guided strategy, DREME-MR decouples cardiac MBCs from respiratory MBCs to resolve the two distinct motion modes. Simultaneously with the pre-treatment dynamic MRI reconstruction, DREME-MR also trains an INR-based motion encoder to infer cardiorespiratory motion coefficients directly from the raw k-space data (learning task 2), allowing real-time, intra-treatment volumetric MR imaging and motion tracking with minimal k-space data (20-30 spokes) acquired after the pre-treatment MRI scan. Evaluated using data from a digital phantom (XCAT) and a human scan, DREME-MR solves real-time 3D cardiorespiratory motion with a latency of < 165 ms (= 150-ms data acquisition + 15-ms inference time), fulfilling the temporal constraint of real-time imaging.

Genetic algorithm as a tool for detection setup optimisation: SiFi-CC case study

2025-07-02T09:56:13Z

Objective: Proton therapy is a precision-focused cancer treatment where accurate proton beam range monitoring is critical to ensure effective dose delivery. This can be achieved by prompt gamma detection with a Compton camera like the SiFi-CC. This study aims to show the feasibility of optimising the geometry of SiFi-CC Compton camera for verification of dose distribution via prompt gamma detection using a genetic algorithm (GA). Approach: The SiFi-CC key geometric parameters for optimisation with the GA are the source-to-scatterer and scatterer-to-absorber distances, and the module thicknesses. The optimisation process was conducted with a software framework based on the Geant4 toolkit, which included detailed and realistic modelling of gamma interactions, detector response, and further steps such as event selection and image reconstruction. The performance of each individual configuration was evaluated using a fitness function incorporating factors related to gamma detection efficiency and image resolution. Results: The GA-optimised SiFi-CC configuration demonstrated the capability to detect a 5 mm proton beam range shift with a 2 mm resolution using 5e8 protons. The best-performing geometry, with 16 fibre layers in the scatterer, 36 layers in the absorber, source-to-scatterer distance 150 mm and scatterer-to-absorber distance 120 mm, has an imaging sensitivity of 5.58(1)e-5. Significance: This study demonstrates that the SiFi-CC setup, optimised through a GA, can reliably detect clinically relevant proton beam range shifts, improving real-time range verification accuracy in proton therapy. The presented implementation of a GA is a systematic and feasible way of searching for a SiFi-CC geometry that shows the best performance.

Positronium Imaging: History, Current Status, and Future Perspectives

2025-07-01T11:55:10Z

Positronium imaging was recently proposed to image the properties of positronium atoms in the patient body. Positronium properties depend on the size of intramolecular voids and oxygen concentration; therefore, they deliver information different and complementary to the anatomic, morphological, and metabolic images. Thus far, the mean ortho-positronium lifetime imaging has been at the center of research interest. The first ex vivo and in vivo positronium lifetime images of humans have been demonstrated with the dedicated J-PET scanner enabling simultaneous registration of annihilation photons and prompt gamma from ${β^{+} γ}$ emitters. Annihilation photons are used to reconstruct the annihilation place and time while prompt gamma is used to reconstruct the time of positronium formation. This review describes recent achievements in the translation of positronium imaging into clinics. The first measurements of positronium lifetime in humans with commercial PET scanners modernized to register triple coincidences are reported. The in vivo observations of differences in ortho-positronium lifetime between tumor and healthy tissues and between different oxygen concentrations are discussed. So far, the positronium lifetime measurements in humans were completed with clinically available ${^{68}\text{Ga}}$, ${^{82}\text{Rb}}$, and ${^{124}\text{I}}$ radionuclides. Status and challenges in developing positronium imaging on a way to a clinically useful procedure are presented and discussed.

Observation of Blood Flow in Major Neck Vessels Modulated 1 by Physiological Maneuvers

2025-06-30T19:59:05Z

Large neck vessels (carotid artery and internal jugular vein, IJV) offer a unique opportunity to monitor hemodynamics non-invasively by optical means. The primary shortcoming of past work has been the focus on healthy volunteers in normal physiological conditions and well-controlled environments. To drive the technology closer to the bedside, testing is required under more re-alistic conditions, including in pathologies and real-world environments (e.g., similar toICU or emergency care settings). The primary goal of the current work was to extend the range of physiological maneuvers for blood flow modulation by introducing new maneuvers and ob-serving PPG response to them. The data from the necks of two healthy volunteers in a supine position were collected by clinical PPG and in-house built PPG sensors, accompanied by ECG signal collection. Seven maneuvers (abdominojugular test, breath holding, Valsalva, proximal occlusion of right IJV, distal occlusion of right IJV, proximal occlusion of left IJV, distal occlusion of left IJV) were performed in sequence with 1 min allocated for each maneuver. The 1 min was split into three segments: baseline (15 s), experiment (15 s), and recovery (30 s). Thus, the overall du-ration of the experiment was 7 min. AC amplitude from clinical PPG, DC amplitudes from in-house built PPG, and ECG signal were compared during all seven physiological maneuvers. Newly proposed maneuvers (Valsalva and IJV occlusions) demonstrated modulation of blood flow, which was more significant than previously reported maneuvers (abdominojugular test and breath holding). The proposed physiological maneuvers demonstrate high potential as instruments for modulating blood flow in major neck vessels.

Scout-Dose-TCM: Direct and Prospective Scout-Based Estimation of Personalized Organ Doses from Tube Current Modulated CT Exams

2025-06-30T17:13:00Z

This study proposes Scout-Dose-TCM for direct, prospective estimation of organ-level doses under tube current modulation (TCM) and compares its performance to two established methods. We analyzed contrast-enhanced chest-abdomen-pelvis CT scans from 130 adults (120 kVp, TCM). Reference doses for six organs (lungs, kidneys, liver, pancreas, bladder, spleen) were calculated using MC-GPU and TotalSegmentator. Based on these, we trained Scout-Dose-TCM, a deep learning model that predicts organ doses corresponding to discrete cosine transform (DCT) basis functions, enabling real-time estimates for any TCM profile. The model combines a feature learning module that extracts contextual information from lateral and frontal scouts and scan range with a dose learning module that output DCT-based dose estimates. A customized loss function incorporated the DCT formulation during training. For comparison, we implemented size-specific dose estimation per AAPM TG 204 (Global CTDIvol) and its organ-level TCM-adapted version (Organ CTDIvol). A 5-fold cross-validation assessed generalizability by comparing mean absolute percentage dose errors and r-squared correlations with benchmark doses. Average absolute percentage errors were 13% (Global CTDIvol), 9% (Organ CTDIvol), and 7% (Scout-Dose-TCM), with bladder showing the largest discrepancies (15%, 13%, and 9%). Statistical tests confirmed Scout-Dose-TCM significantly reduced errors vs. Global CTDIvol across most organs and improved over Organ CTDIvol for the liver, bladder, and pancreas. It also achieved higher r-squared values, indicating stronger agreement with Monte Carlo benchmarks. Scout-Dose-TCM outperformed Global CTDIvol and was comparable to or better than Organ CTDIvol, without requiring organ segmentations at inference, demonstrating its promise as a tool for prospective organ-level dose estimation in CT.

Supervised Diffusion-Model-Based PET Image Reconstruction

2025-06-30T16:39:50Z

Diffusion models (DMs) have recently been introduced as a regularizing prior for PET image reconstruction, integrating DMs trained on high-quality PET images with unsupervised schemes that condition on measured data. While these approaches have potential generalization advantages due to their independence from the scanner geometry and the injected activity level, they forgo the opportunity to explicitly model the interaction between the DM prior and noisy measurement data, potentially limiting reconstruction accuracy. To address this, we propose a supervised DM-based algorithm for PET reconstruction. Our method enforces the non-negativity of PET's Poisson likelihood model and accommodates the wide intensity range of PET images. Through experiments on realistic brain PET phantoms, we demonstrate that our approach outperforms or matches state-of-the-art deep learning-based methods quantitatively across a range of dose levels. We further conduct ablation studies to demonstrate the benefits of the proposed components in our model, as well as its dependence on training data, parameter count, and number of diffusion steps. Additionally, we show that our approach enables more accurate posterior sampling than unsupervised DM-based methods, suggesting improved uncertainty estimation. Finally, we extend our methodology to a practical approach for fully 3D PET and present example results from real [$^{18}$F]FDG brain PET data.

Pixel super-resolved virtual staining of label-free tissue using diffusion models

2025-06-30T16:15:48Z

Virtual staining of tissue offers a powerful tool for transforming label-free microscopy images of unstained tissue into equivalents of histochemically stained samples. This study presents a diffusion model-based super-resolution virtual staining approach utilizing a Brownian bridge process to enhance both the spatial resolution and fidelity of label-free virtual tissue staining, addressing the limitations of traditional deep learning-based methods. Our approach integrates novel sampling techniques into a diffusion model-based image inference process to significantly reduce the variance in the generated virtually stained images, resulting in more stable and accurate outputs. Blindly applied to lower-resolution auto-fluorescence images of label-free human lung tissue samples, the diffusion-based super-resolution virtual staining model consistently outperformed conventional approaches in resolution, structural similarity and perceptual accuracy, successfully achieving a super-resolution factor of 4-5x, increasing the output space-bandwidth product by 16-25-fold compared to the input label-free microscopy images. Diffusion-based super-resolved virtual tissue staining not only improves resolution and image quality but also enhances the reliability of virtual staining without traditional chemical staining, offering significant potential for clinical diagnostics.

Fourier-based Inversion of Partial X-ray Transforms in n Dimensions

2025-06-30T06:53:37Z

We present two theorems describing analytic left-inverses of partial X-ray transforms. The first theorem concerns X-ray data collected with an arbitrary distribution of parallel projections; it contains a convolution-backprojection formula and a backprojection-convolution formula for recovering the transformed volume, provided the data is sufficient. The second theorem concerns X-ray data collected with a cone-beam; it contains a backprojection-convolution formula for recovering the transformed volume, provided the data is amenable to this method (for example: (n-1)-dimensional source loci that `surround' the reconstruction support; detectors of finite size are supported). These theorems are the outcome of a modestly general and rigorous investigation undertaken into the existence of backprojection-convolution methods in n-dimensional space. Necessary and sufficient conditions on the experiment geometry are established for the existence of such methods, as are the particular error metrics minimised by backprojection-convolution methods and the uniqueness of those minimum-error solutions. A major practical outcome of this work is the production of the first known exact inversion methods for cone-beam geometries where the X-ray source point loci are multidimensional, such as (in 3D) a cylinder or a sphere of X-ray source positions. A separate article describes a practical computer implementation for the case of a cylinder in 3D.

Artificial Intelligence-assisted Pixel-level Lung (APL) Scoring for Fast and Accurate Quantification in Ultra-short Echo-time MRI

2025-06-30T04:08:42Z

Lung magnetic resonance imaging (MRI) with ultrashort echo-time (UTE) represents a recent breakthrough in lung structure imaging, providing image resolution and quality comparable to computed tomography (CT). Due to the absence of ionising radiation, MRI is often preferred over CT in paediatric diseases such as cystic fibrosis (CF), one of the most common genetic disorders in Caucasians. To assess structural lung damage in CF imaging, CT scoring systems provide valuable quantitative insights for disease diagnosis and progression. However, few quantitative scoring systems are available in structural lung MRI (e.g., UTE-MRI). To provide fast and accurate quantification in lung MRI, we investigated the feasibility of novel Artificial intelligence-assisted Pixel-level Lung (APL) scoring for CF. APL scoring consists of 5 stages, including 1) image loading, 2) AI lung segmentation, 3) lung-bounded slice sampling, 4) pixel-level annotation, and 5) quantification and reporting. The results shows that our APL scoring took 8.2 minutes per subject, which was more than twice as fast as the previous grid-level scoring. Additionally, our pixel-level scoring was statistically more accurate (p=0.021), while strongly correlating with grid-level scoring (R=0.973, p=5.85e-9). This tool has great potential to streamline the workflow of UTE lung MRI in clinical settings, and be extended to other structural lung MRI sequences (e.g., BLADE MRI), and for other lung diseases (e.g., bronchopulmonary dysplasia).

FD-DiT: Frequency Domain-Directed Diffusion Transformer for Low-Dose CT Reconstruction

2025-06-30T02:16:38Z

Low-dose computed tomography (LDCT) reduces radiation exposure but suffers from image artifacts and loss of detail due to quantum and electronic noise, potentially impacting diagnostic accuracy. Transformer combined with diffusion models has been a promising approach for image generation. Nevertheless, existing methods exhibit limitations in preserving finegrained image details. To address this issue, frequency domain-directed diffusion transformer (FD-DiT) is proposed for LDCT reconstruction. FD-DiT centers on a diffusion strategy that progressively introduces noise until the distribution statistically aligns with that of LDCT data, followed by denoising processing. Furthermore, we employ a frequency decoupling technique to concentrate noise primarily in high-frequency domain, thereby facilitating effective capture of essential anatomical structures and fine details. A hybrid denoising network is then utilized to optimize the overall data reconstruction process. To enhance the capability in recognizing high-frequency noise, we incorporate sliding sparse local attention to leverage the sparsity and locality of shallow-layer information, propagating them via skip connections for improving feature representation. Finally, we propose a learnable dynamic fusion strategy for optimal component integration. Experimental results demonstrate that at identical dose levels, LDCT images reconstructed by FD-DiT exhibit superior noise and artifact suppression compared to state-of-the-art methods.

Physics informed guided diffusion for accelerated multi-parametric MRI reconstruction

2025-06-29T16:00:32Z

We introduce MRF-DiPh, a novel physics informed denoising diffusion approach for multiparametric tissue mapping from highly accelerated, transient-state quantitative MRI acquisitions like Magnetic Resonance Fingerprinting (MRF). Our method is derived from a proximal splitting formulation, incorporating a pretrained denoising diffusion model as an effective image prior to regularize the MRF inverse problem. Further, during reconstruction it simultaneously enforces two key physical constraints: (1) k-space measurement consistency and (2) adherence to the Bloch response model. Numerical experiments on in-vivo brain scans data show that MRF-DiPh outperforms deep learning and compressed sensing MRF baselines, providing more accurate parameter maps while better preserving measurement fidelity and physical model consistency-critical for solving reliably inverse problems in medical imaging.

Derivation of Tissue Properties from Basis-Vector Model Weights for Dual-Energy CT-Based Monte Carlo Proton Beam Dose Calculations

2025-06-27T17:47:05Z

We propose a novel method, basis vector model material indexing (BVM-MI), for predicting atomic composition and mass density from two independent basis vector model weights derived from dual-energy CT (DECT) for Monte Carlo (MC) dose planning. BVM-MI employs multiple linear regression on BVM weights and their quotient to predict elemental composition and mass density for 70 representative tissues. Predicted values were imported into the TOPAS MC code to simulate proton dose deposition to a uniform cylinder phantom composed of each tissue type. The performance of BVM-MI was compared to the conventional Hounsfield Unit material indexing method (HU-MI), which estimates elemental composition and density based on CT numbers (HU). Evaluation metrics included absolute errors in predicted elemental compositions and relative percent errors in calculated mass density and mean excitation energy. Dose distributions were assessed by quantifying absolute error in the depth of 80% maximum scored dose (R80) and relative percent errors in stopping power (SP) between MC simulations using HU-MI, BVM-MI, and benchmark compositions. Lateral dose profiles were analyzed at R80 and Bragg Peak (RBP) depths for three tissues showing the largest discrepancies in R80 depth. BVM-MI outperformed HU-MI in elemental composition predictions, with mean RMSEs of 1.30% (soft tissue) and 0.1% (bony tissue), compared to 4.20% and 1.9% for HU-MI. R80 depth RMSEs were 0.2 mm (soft) and 0.1 mm (bony) for BVM-MI, vs. 1.8 mm and 0.7 mm for HU-MI. Lateral dose profile analysis showed overall smaller dose errors for BVM-MI across core, halo, and proximal aura regions. In conclusion, fully utilizing the two-parameter BVM space for material indexing led to significantly improved TOPAS MC dose calculations over the conventional HU-MI method, demonstrating BVM-MI's potential to enhance proton therapy planning.

Simulation-based digital twinning of activation and repolarisation sequences from the ECG across healthy and diseased hearts

2025-06-27T14:10:10Z

Abnormal patterns of ventricular repolarisation contribute to lethal arrhythmias in various cardiac conditions, including inherited and acquired channelopathies, cardiomyopathies, and ischaemic heart disease. However, methods to detect these repolarisation abnormalities are limited. In this study, we introduce and assess a novel simulation-based method to infer ventricular activation and repolarisation times from the 12-lead electrocardiogram (ECG) and magnetic resonance-derived ventricular anatomical reconstruction, applicable for the first time to both healthy controls and cases with abnormal repolarisation. First, ventricular activation times were reconstructed through iterative refinement of early activation sites and conduction velocities, until the model and target QRS complexes matched. Then, ventricular repolarisation times were reconstructed through iterative refinement of ventricular action potential durations and an action potential shape parameter until the model and target T waves matched, including regularisation. Repolarisation inference was evaluated against 18 benchmark simulations with known repolarisation times, including both control and hypertrophic cardiomyopathy (HCM) cases with abnormal repolarisation. Inferred repolarisation times showed good agreement with the ground truth in control and HCM (Spearman r=0.63+/-0.11 and 0.65+/-0.19, respectively), with inferred model T waves closely matching the target T waves (r=0.81+/-0.05 and 0.78+/-0.08, respectively). The method further demonstrated flexibility in reconstructing the macroscopic patterns of delayed repolarisation across a range of abnormal ventricular repolarisation sequences, demonstrating applicability to a range of pathological cases. Simulation-based inference can accurately reconstruct repolarisation times from the 12-lead ECG in cases with both normal and abnormal repolarisation patterns.

Characterization Of Diseases In Temporal Comorbidity Networks

2025-06-27T11:24:19Z

Comorbidity networks, which capture disease-disease co-occurrence usually based on electronic health records, reveal structured patterns in how diseases cluster and progress across individuals. However, how these networks evolve across different age groups and how this evolution relates to properties like disease prevalence and mortality remains understudied. To address these issues, we used publicly available comorbidity networks extracted from a comprehensive dataset of 45 million Austrian hospital stays from 1997 to 2014, covering 8.9 million patients. These networks grow and become denser with age. We identified groups of diseases that exhibit similar patterns of structural centrality throughout the lifespan, revealing three dominant age-related components with peaks in early childhood, midlife, and late life. To uncover the drivers of this structural change, we examined the relationship between prevalence and degree. This allowed us to identify conditions that were disproportionately connected to other diseases. Using betweenness centrality in combination with mortality data, we further identified high-mortality bridging diseases. Several diseases show high connectivity relative to their prevalence, such as iron deficiency anemia (D50) in children, nicotine dependence (F17), and lipoprotein metabolism disorders (E78) in adults. We also highlight structurally central diseases with high mortality that emerge at different life stages, including cancers (C group), liver cirrhosis (K74), subarachnoid hemorrhage (I60), and chronic kidney disease (N18). These findings underscore the importance of targeting age-specific, network-central conditions with high mortality for prevention and integrated care.